Fluorodeoxyglucose positron emission tomography detects the inflammatory phase of scleroring peritonitis

Peritoneal Dialysis International

Volumn 26, Issue 2, 2006, Pages 224-230

  Tarzi, Ruth M ^a   Frank, John W ^a   Ahmad, Sohail ^a   Levy, Jeremy B ^a   Brown, Edwina A ^a  

^a CHARING CROSS HOSPITAL   (United Kingdom)

Author keywords

Complications of peritoneal dialysis; Encapsulating sclerosing peritonitis; FDG PET scan; Sclerosing peritonitis

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DIABETIC NEPHROPATHY; DIAGNOSTIC VALUE; DRUG UPTAKE; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; INFLAMMATION; KIDNEY FAILURE; KIDNEY POLYCYSTIC DISEASE; LONG TERM CARE; MALE; NEPHROLITHIASIS; PERITONEAL DIALYSIS; PERITONEAL DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SCLEROSING PERITONITIS; SYMPTOM; CASE REPORT; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; FEMALE; MIDDLE AGED; PATHOLOGY; PERITONEUM; PERITONITIS; SCINTISCANNING; SCLEROSIS;

ADULT; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; PERITONEUM; PERITONITIS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; SCLEROSIS;

EID: 33747110729     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080602600219     Document Type: Article

References (14)

1. Bradley JA, McWhinnie DL, Hamilton DN, Starnes F, MacPherson SG, Seywright M, et al. Sclerosing obstructive peritonitis after continuous ambulatory peritoneal dialysis. Lancet 1983; 2:113-14.
2. Rottembourg J, Gahl GM, Poignet JL, Mertani E, Strippoli P, Langlois P, et al. Severe abdominal complications in patients undergoing continuous ambulatory peritoneal dialysis. Proc Eur Dial Transplant Assoc 1983; 20:236-42.
3. Oules R, Challah S, Brunner FP. Case-control study to determine the cause of sclerosing peritoneal disease. Nephrol Dial Transplant 1988; 3:66-9.
4. Nomoto Y, Kawaguchi Y, Kubo H, Hirano H, Sakai S, Kurokawa K. Sclerosing encapsulating peritonitis in patients undergoing continuous ambulatory peritoneal dialysis: a report of the Japanese Sclerosing Encapsulating Peritonitis Study Group. Am J Kidney Dis 1996; 28:420-7.
5. Rigby RJ, Hawley CM. Sclerosing peritonitis: the experience in Australia. Nephrol Dial Transplant 1998; 13:154-9.
6. Kawanishi H, Kawaguchi Y, Fukui H, Hara S, Imada A, Kubo H, et al. Encapsulating peritoneal sclerosis in Japan: a prospective, controlled, multicenter study. Am J Kidney Dis 2004; 44:729-37.
7. Kawanishi H, Harada Y, Noriyuki T, Kawai T, Takahashi S, Moriishi M, et al. Treatment options for encapsulating peritoneal sclerosis based on progressive stage. Adv Perit Dial 2001; 17:200-4.
8. Krestin GP, Kacl G, Hauser M, Keusch G, Burger HR, Hoffmann R. Imaging diagnosis of sclerosing peritonitis and relation of radiologic signs to the extent of the disease. Abdom Imaging 1995; 20:414-20.
9. Stafford-Johnson DB, Wilson TE, Francis IR, Swartz R. CT appearance of sclerosing peritonitis in patients on chronic ambulatory peritoneal dialysis. J Comput Assist Tomogr 1998; 22:295-9.
10. Alavi A, Kung JW, Zhuang H. Implications of PET based molecular imaging on the current and future practice of medicine. Semin Nucl Med 2004; 34:56-69.
11. Kubota K, Yamada K, Yoshioka S, Yaniada S, Ito M, Ido T. Differential diagnosis of idiopathic fibrosis from malignant lymphadenopathy with PET and F-18 fluorodeoxyglucose. Clin Nucl Med 1992; 17:361-3.
12. Turlakow A, Yeung HW, Salmon AS, Macapinlac HA, Larson SM. Peritoneal carcinomatosis: role of (18)F-FDG PET. J Nucl Med 2003; 44:1407-12.
13. Jeffry L, Kerrou K, Camatte S, Lelievre L, Metzger U, Robin F, et al. Peritoneal tuberculosis revealed by carcinomatosis on CT scan and uptake at FDG-PET. BJOG 2003; 110: 1129-31.
14. Nakayama M, Yamamoto H, Ikeda M, Hasegawa T, Kato N, Takahashi H, et al. Risk factors and preventive measures for encapsulating peritoneal sclerosis - Jikei experience 2002. Adv Perit Dial 2002; 18:144-8.